Biodesix Inc. Files 8-K Report
Ticker: BDSX · Form: 8-K · Filed: Oct 1, 2025 · CIK: 1439725
| Field | Detail |
|---|---|
| Company | Biodesix Inc (BDSX) |
| Form Type | 8-K |
| Filed Date | Oct 1, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001, $1.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, other-events
TL;DR
Biodesix filed an 8-K, but no juicy details yet.
AI Summary
On September 26, 2025, Biodesix Inc. filed an 8-K report to disclose other events. The filing does not specify any material events or transactions that occurred on this date. The company's principal executive offices are located at 919 West Dillon Road, Louisville, CO 80027.
Why It Matters
This 8-K filing indicates that Biodesix Inc. has made a regulatory submission, but it does not provide details on any specific material events that would immediately impact investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for 'Other Events' and does not disclose any specific material information that would inherently increase risk.
Key Players & Entities
- Biodesix Inc. (company) — Registrant
- September 26, 2025 (date) — Date of earliest event reported
- 919 West Dillon Road, Louisville, CO 80027 (location) — Principal executive offices
FAQ
What specific 'Other Events' are being reported by Biodesix Inc. in this 8-K filing?
The provided text of the 8-K filing does not specify the details of the 'Other Events' being reported; it only indicates that the filing is for this item category.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on September 26, 2025.
What is the principal executive office address for Biodesix Inc.?
The principal executive office address for Biodesix Inc. is 919 West Dillon Road, Louisville, CO 80027.
Under which section of the Securities Exchange Act of 1934 is this 8-K report filed?
This 8-K report is filed pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934.
What is the state of incorporation for Biodesix Inc.?
Biodesix Inc. is incorporated in Delaware.
Filing Stats: 521 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2025-10-01 16:05:22
Key Financial Figures
- $0.001 — ich Registered Common Stock, par value $0.001 per share BDSX The Nasdaq Stock Mar
- $1.00 — e "Common Stock"), had closed below the $1.00 per share minimum for 30 consecutive bu
Filing Documents
- d20952d8k.htm (8-K) — 23KB
- 0001193125-25-226749.txt ( ) — 134KB
- bdsx-20250926.xsd (EX-101.SCH) — 3KB
- bdsx-20250926_lab.xml (EX-101.LAB) — 18KB
- bdsx-20250926_pre.xml (EX-101.PRE) — 11KB
- d20952d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: October 1, 2025 BIODESIX, INC. By: /s/ Robin Harper Cowie Name: Robin Harper Cowie Title: Chief Financial Officer